Medicine & Life Sciences
HIV-1
100%
HIV
97%
Highly Active Antiretroviral Therapy
35%
Child
33%
Nevirapine
32%
Viremia
31%
T-Lymphocytes
29%
HIV Infections
28%
Drug Resistance
23%
Viral Load
19%
Viruses
19%
Reverse Transcriptase Inhibitors
17%
Therapeutics
16%
GSK1265744
16%
Infections
15%
Virus Diseases
14%
DNA
13%
RNA
12%
Poxviridae
11%
Acquired Immunodeficiency Syndrome
11%
Pediatrics
11%
Pharmaceutical Preparations
10%
Mutation
10%
Mothers
10%
Secondary Prevention
9%
Newborn Infant
9%
Proviruses
9%
Breast Feeding
9%
Young Adult
9%
Biomarkers
8%
Pharmacokinetics
8%
Rotavirus Vaccines
7%
Protease Inhibitors
7%
AIDS Vaccines
7%
Scientific Societies
7%
Blood Cells
7%
Proof of Concept Study
7%
Vertical Infectious Disease Transmission
7%
Virus Replication
6%
Ritonavir
6%
Lymphocyte Activation
6%
Safety
5%
Limit of Detection
5%
Nelfinavir
5%
National Institute of Allergy and Infectious Diseases (U.S.)
5%
CD4 Lymphocyte Count
5%
Agriculture & Biology
Human immunodeficiency virus 1
24%
therapeutics
14%
T-lymphocytes
13%
viremia
11%
viruses
10%
Poxviridae
7%
assays
7%
drugs
6%
viral load
6%
lymphocyte proliferation
6%